Merck & Co (MRK)
Healthcare • Drug Manufacturers - General
StockNYSEUnited StatesUS58933Y1055
146.95 USD
-0.16% today Updated 12 Nov 2026 21:29
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Merck & Co, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:29. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
02 Feb 2027
in 81 days · 08:00 · estimate 1.76
Last results
2.49 vs 2.08 estimated
29 Oct 2026 · Beat +19.6%
Beat the estimate
11 of 12
0 missed · 1 in line · 8 beats in a row
Average surprise
+20.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Feb 2027 08:00 | 1.76 | — | — | Upcoming |
| 29 Oct 2026 06:00 | 2.08 | 2.49 | +19.6% | Beat |
| 04 Aug 2026 06:00 | -0.26 | -0.13 | +49.4% | Beat |
| 30 Apr 2026 06:00 | -1.47 | -1.28 | +13.2% | Beat |
| 03 Feb 2026 06:00 | 2.01 | 2.04 | +1.5% | Beat |
| 30 Oct 2025 06:00 | 2.35 | 2.58 | +9.9% | Beat |
| 29 Jul 2025 06:00 | 2.03 | 2.13 | +5.0% | Beat |
| 24 Apr 2025 06:00 | 2.14 | 2.22 | +4.0% | Beat |
| 04 Feb 2025 06:00 | 1.67 | 1.72 | +3.3% | Beat |
| 31 Oct 2024 06:00 | 1.57 | 1.57 | +0.0% | In line |
| 30 Jul 2024 06:00 | 2.14 | 2.28 | +6.3% | Beat |
| 25 Apr 2024 06:00 | 1.92 | 2.07 | +7.7% | Beat |
| 01 Feb 2024 06:00 | -0.11 | 0.03 | +127.5% | Beat |
| 26 Oct 2023 06:00 | 1.95 | 2.13 | +9.5% | Beat |
| 01 Aug 2023 06:00 | -2.18 | -2.06 | +5.4% | Beat |
| 27 Apr 2023 06:00 | 1.34 | 1.40 | +4.8% | Beat |
| 02 Feb 2023 06:00 | 1.54 | 1.62 | +5.4% | Beat |
| 27 Oct 2022 06:00 | 1.71 | 1.85 | +8.3% | Beat |
| 28 Jul 2022 06:00 | 1.71 | 1.87 | +9.6% | Beat |
| 28 Apr 2022 06:00 | 1.83 | 2.14 | +17.1% | Beat |
| 03 Feb 2022 06:00 | 1.52 | 1.80 | +18.1% | Beat |
| 28 Oct 2021 06:00 | 1.55 | 1.75 | +12.6% | Beat |
| 29 Jul 2021 06:00 | 1.35 | 1.31 | -2.9% | Miss |
| 29 Apr 2021 06:00 | 1.61 | 1.40 | -13.2% | Miss |
| 04 Feb 2021 06:00 | 1.39 | 1.32 | -4.9% | Miss |
| 27 Oct 2020 06:00 | 1.43 | 1.74 | +21.3% | Beat |
| 31 Jul 2020 06:00 | 1.09 | 1.37 | +25.8% | Beat |
| 28 Apr 2020 07:00 | 1.34 | 1.50 | +11.8% | Beat |
| 05 Feb 2020 06:00 | 1.15 | 1.16 | +1.2% | Beat |
| 29 Oct 2019 06:00 | 1.24 | 1.51 | +21.6% | Beat |
| 30 Jul 2019 06:00 | 1.16 | 1.30 | +12.2% | Beat |
| 30 Apr 2019 06:00 | 1.05 | 1.22 | +15.8% | Beat |
| 01 Feb 2019 06:00 | 1.03 | 1.04 | +0.6% | In line |
| 25 Oct 2018 06:00 | 1.14 | 1.19 | +4.3% | Beat |
| 27 Jul 2018 06:00 | 1.03 | 1.06 | +2.8% | Beat |
| 01 May 2018 06:00 | 1.00 | 1.05 | +5.5% | Beat |
| 02 Feb 2018 06:00 | 0.94 | 0.98 | +4.7% | Beat |
| 27 Oct 2017 06:00 | 1.03 | 1.11 | +7.6% | Beat |
| 28 Jul 2017 06:00 | 0.87 | 1.01 | +15.5% | Beat |
| 02 May 2017 06:00 | 0.83 | 0.88 | +5.9% | Beat |
| 02 Feb 2017 06:00 | 0.89 | 0.89 | +0.1% | In line |
| 25 Oct 2016 06:00 | 0.99 | 1.07 | +8.2% | Beat |
| 29 Jul 2016 06:00 | 0.91 | 0.93 | +2.1% | Beat |
| 05 May 2016 06:00 | 0.85 | 0.89 | +4.6% | Beat |
| 03 Feb 2016 06:00 | 0.91 | 0.93 | +1.9% | Beat |
| 27 Oct 2015 06:00 | 0.92 | 0.96 | +4.8% | Beat |
| 28 Jul 2015 07:00 | 0.81 | 0.86 | +6.1% | Beat |
| 28 Apr 2015 07:00 | 0.75 | 0.85 | +13.7% | Beat |
| 04 Feb 2015 07:00 | 0.86 | 0.87 | +1.6% | Beat |
| 27 Oct 2014 07:00 | 0.88 | 0.90 | +2.5% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 65B | +1.3% | 18.3B | 28.1% | 7.28 | +8.0% | 12.4B |
| 2024 | 64.2B | +6.7% | 17.1B | 26.7% | 6.74 | +4,714.3% | 18.1B |
| 2023 | 60.1B | +1.4% | 365M | 0.6% | 0.14 | -97.5% | 9.1B |
| 2022 | 59.3B | — | 14.5B | 24.5% | 5.71 | — | 14.7B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 148.61 | 149.31 | 146.86 | 146.95 | -0.16% | 5,887,526 | |
| 11 Nov 2026 | 146.61 | 147.62 | 145.30 | 147.18 | -0.59% | 6,411,300 | |
| 10 Nov 2026 | 148.40 | 149.19 | 145.58 | 148.05 | -0.48% | 5,509,900 | |
| 09 Nov 2026 | 148.37 | 148.80 | 146.52 | 148.76 | +1.38% | 7,560,200 | |
| 06 Nov 2026 | 144.34 | 147.48 | 142.80 | 146.73 | -0.14% | 7,626,300 | |
| 05 Nov 2026 | 152.00 | 153.37 | 146.55 | 146.94 | -2.27% | 11,547,600 | |
| 04 Nov 2026 | 148.54 | 150.42 | 146.05 | 150.36 | +3.93% | 10,712,700 | |
| 03 Nov 2026 | 147.02 | 147.62 | 143.47 | 144.67 | -2.49% | 8,894,400 | |
| 02 Nov 2026 | 148.82 | 150.27 | 147.10 | 148.36 | -0.78% | 9,095,400 | |
| 30 Oct 2026 | 149.55 | 151.35 | 147.40 | 149.52 | +2.18% | 12,341,400 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Merck (MRK) Could Be 7% Undervalued As MASH Trial Data Lifts Optimism (opens in a new tab) Simply Wall St. · 11 Nov 2026 05:13
- Merck Shares Rose Even As Profit Fell (opens in a new tab) Simply Wall St. · 11 Nov 2026 04:35
- Merck vs. Gilead Sciences: Which Dividend Stock Pays You More in 10 Years? (opens in a new tab) TIKR · 10 Nov 2026 17:57
- Nucleic Acid Labeling - Global Strategic Business Report 2026: Secure Share of a $2.8 Billion Market by 2032 as Thermo Fisher Scientific, Roche, Merck, and Agilent Accelerate Genomics (opens in a new tab) 10 Nov 2026 15:00
- In Vitro Toxicology Testing - Global Strategic Business Report: Capitalize on the $14B-to-$27.4B Surge as Thermo Fisher Scientific, Merck, Eurofins and Bio-Rad Disrupt Testing by 2032 (opens in a new tab) 10 Nov 2026 14:58
- Can You Still Buy Merck Stock Today? (opens in a new tab) Trefis · 10 Nov 2026 13:11
- Merck Announces Positive Results from Phase 2b Trial of Efinopegdutide in Adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Stage 2-3 Fibrosis (opens in a new tab) 09 Nov 2026 18:05
- Moderna Soars Another 9% as Piper Sandler Lifts Target to $305 on Raised Outlook (opens in a new tab) TIKR · 09 Nov 2026 16:35
- INVA or MRK: Which Is the Better Value Stock Right Now? (opens in a new tab) Zacks · 09 Nov 2026 15:40
- Global Arrayed CRISPR Screening Market Report 2026 | Capitalize on 17.7% CAGR to $3.43 Billion as Thermo Fisher, Merck, Agilent and GenScript Advance Precision Drug Discovery (opens in a new tab) 09 Nov 2026 14:09
- Merck Reports Phase 2b Results For Efinopegdutide In MASH, Meaningful Improvements Were Observed In Liver Fibrosis Without Worsening Of Steatohepatitis, A Key Secondary Histologic Endpoint; Results Presented At The Liver Meeting And Published In The Lancet (opens in a new tab) Benzinga · 09 Nov 2026 14:08
- MRK's 2027 Outlook Challenging, Long-Term Prospects Promising (opens in a new tab) Zacks · 09 Nov 2026 12:48
- Merck (MRK) Starts ENHANCE 3 COPD Trial As Cancer Drug Review Nears (opens in a new tab) Simply Wall St. · 09 Nov 2026 11:07
- Is Merck (MRK) Undervalued After Its Cancer Trial Wins? (opens in a new tab) Simply Wall St. · 09 Nov 2026 10:07
- Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck (opens in a new tab) Zacks · 09 Nov 2026 09:20
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 147.18 USD
- Market cap
- 362.8B
- Dividend yield
- 2.31%
- 5-year average yield
- 2.87%
- Payout ratio
- 343%
- Last dividend
- 0.8500 USD · 15 Sep 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 15 Sep 2026 | 0.8500 USD |
| 15 Jun 2026 | 0.8500 USD |
| 16 Mar 2026 | 0.8500 USD |
| 15 Dec 2025 | 0.8500 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow MRK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.